By Kamal Choudhury March 26 (Reuters) - Wave Life Sciences shares plunged 58% on Thursday after a higher dose of its experimental obesity drug failed to show a clear improvement at reducing a ...

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the ...

One of the world’s leading investment firms has broken its own record with the closing of its $6.3 billion Blackstone Life ...

The average one-year price target for Wave Life Sciences (NasdaqGM:WVE) has been revised to $28.29 / share. This is a decrease of 20.34% from the prior estimate of $35.51 dated March 25, 2026. The ...

The organizations that thrive during uncertain times are the ones who learn to keep moving even when visibility is limited.

TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the "Company"), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to ...

Blackstone (NYSE: BX) today announced the final close of Blackstone Life Sciences VI ("BXLS VI"). BXLS VI was oversubscribed and closed at its hard cap of $6.3 billion of total capital commitments. It ...

Blackstone Inc. closed its latest life-sciences fund with $6.3 billion of commitments, the firm’s biggest haul for backing ...

Wave Life Sciences (NASDAQ:WVE) shares are trading near historic lows after two Wall Street firms cut their price targets ...

Behavior Labs delivers intelligence from day zero using public, regulatory, and commercial data sources, then compounds in value as teams layer in their own strategic context — all within a secure, ...

April 01, 2026 - PRESSADVANTAGE - As clinical research, pharmaceutical development, and medical device innovation ...

What’s driving success for the UK’s life sciences businesses and what’s standing in their way? UK Life Sciences Future50 ...